Table 3

Pain experience and analgesia use reported at day 4 following treatment

Experienced painEntire cohort (n=663)Gestation under 10 weeks (n=642)Gestation 10 weeks – 11 weeks and 6 days (n=21)
Yes624 (94.1%)603 (93.9%)21 (100%)
No22 (3.3%)22 (3.4%)0
Unknown17 (2.6%)17 (2.6%)0
Pain score of those answering ‘Yes’ to pain experienced*Cohort reporting pain score (n=610, 14 did not report pain score)Gestation under 10 weeks (n=589)Gestation 10 weeks – 11 weeks and 6 days (n=21)
Median777
Mean6.76.77.0
SD2.22.22.0
Pain experienced compared with expectation, of those providing a pain scoreCohort responding (n=587, 23 did not respond)Gestation under 10 weeks (n=568, 21 did not respond)Gestation 10 weeks – 11 weeks and 6 days (n=19, 2 did not respond)
Better than expected227 (38.7%)217 (38.2%)10 (52.6%)
Same as expected148 (25.2%)144 (25.4%)4 (21.1%)
Worse than expected212 (36.1%)207 (36.4%)5 (26.3%)
Used analgesiaEntire cohort (n=663)Gestation under 10 weeks (n=642)Gestation 10 weeks – 11 weeks and 6 days (n=21)
Yes†616 (92.9%)596 (92.8%)20 (95.2%)
No30 (4.5%)29 (4.5%)1 (4.8%)
Unknown17 (2.6%)17 (2.6%)0
ParacetamolYes610 (92.0%)593 (92.4%)17 (81.0%)
No36 (5.4%)32 (5.0%)4 (19.0%)
IbuprofenYes403 (60.9%)390 (60.7%)13 (61.9%)
No243 (36.7%)235 (36.6%)8 (38.1%)
Dihydrocodeine‡Yes427 (64.4%)413 (64.3%)14 (66.7%)
No219 (33.0%)212 (33.0%)7 (33.3%)
  • *Pain score on an 11-point Likert scale from 0 to 10, and comparison of pain experienced with expectations of pain.

  • †Yes includes use of paracetamol, ibuprofen, dihydrocodeine, or any other pain relief treatment.

  • ‡Patients were given five doses of dihydrocodeine 30 mg in their treatment packs and directed to purchase their own paracetamol and ibuprofen.